Editorial

Off the Rack

Authors: Grant V. Chow, MD, Roy C. Ziegelstein, MD

Abstract

Core competencies. Pay for performance. Physician, hospital, and health plan “report cards.” In medicine, we are growing accustomed to having our performance measured, rather than having it simply assumed. Society wants to be able to choose the best provider in the best system by evaluating objective evidence rather than just reputation. And it makes sense. Imagine buying a suit or a dress “off the rack” without first trying it on. What if we were told, “People with your height, weight, and measurements generally like it, and so will you.”

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Ellahham S. Role of antiplatelet agents in the primary and secondary prevention of atherothrombotic events. South Med J 2008;101:273–283.
 
2. Harrington RA, Becker RC, Ezekowitz M, et al: Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:513S–548S.
 
3. Campbell CL, Smyth S, Montalescot G, et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA 2007;297:2018–2024.
 
4. MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003;361:573–574.
 
5. Kurth T, Glynn RJ, Walker AM, et al. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal anti-inflammatory drugs. Circulation 2003;108:1191–1195.
 
6. Barnes GD, Li J, Kline-Rogers E, et al. Dual antiplatelet agent failure: a new syndrome or clinical nonentity? Am Heart J 2007;154:732–735.
 
7. Snoep JD, Hovens MM, Eikenboom JC, et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007;167:1593–1599.
 
8. Gurbel PA, Bliden KP, DiChiara J, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 2007;155:3156–3164.
 
9. Miner J, Hoffhines A. The discovery of aspirin's antithrombotic effects. Tex Heart Inst J 2007;34:179–186.